ストックスクリーナーアプリを入手
1.70
4.94%
0.08
アフターアワーズ：
1.70
前日終値:
$1.62
開ける：
$1.6
24時間の取引高:
125.86K
Relative Volume:
0.10
時価総額：
$4.43M
収益：
$142.00K
当期純損益:
$-1.23M
株価収益率:
3.6504
EPS:
0.4657
ネットキャッシュフロー:
$-10.62M
1週間 パフォーマンス:
-5.56%
1か月 パフォーマンス:
-17.07%
6か月 パフォーマンス:
-50.72%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$1.58
$1.79
1週間の範囲:
$1.55
$1.8165
52週間の値動き範囲:
$1.41
$5.30
Vivosim Labs Inc Stock (VIVS) Company Profile
Compare VIVS vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VIVS
Vivosim Labs Inc
|
1.70 | 4.22M | 142.00K | -1.23M | -10.62M | 0.4657 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2018-12-13 | 開始されました | H.C. Wainwright | Buy |
| 2017-11-10 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2017-01-25 | 開始されました | Raymond James | Outperform |
| 2015-08-11 | ダウングレード | Cantor Fitzgerald | Buy → Hold |
| 2015-06-29 | 開始されました | Jefferies | Buy |
| 2015-06-29 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Vivosim Labs Inc (VIVS) 最新ニュース
VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing - GlobeNewswire
VivoSim Labs, Inc.: Fundamental Analysis and Financial Ratings | 4OR | US68620A3023 - marketscreener.com
Market Catalysts: What is the cash position of VivoSim Labs Inc2026 Price Swings & Reliable Trade Execution Plans - baoquankhu1.vn
Is VivoSim Labs Inc. stock a buy before product launchesJuly 2025 Rallies & Safe Capital Investment Plans - Naître et grandir
Buyback Watch: How much upside does VivoSim Labs Inc haveTrade Analysis Summary & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Why Is VIVS Stock Up 79% Today? - Stocktwits
VIVS Earnings History & Surprises | EPS & Revenue Results | VIVOSIM LABS INC (NASDAQ:VIVS) - ChartMill
VivoSim names Raghunathan as VP of global sales By Investing.com - Investing.com Canada
VivoSim names Raghunathan as VP of global sales - Investing.com Nigeria
Vivosim appoints Arumugham (Ragoo) Raghunathan as vice president of global sales - marketscreener.com
VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales - GlobeNewswire
VIVS Should I Buy - Intellectia AI
VIVS Technical Analysis & Stock Price Forecast - Intellectia AI
Exit Recap: Is VivoSim Labs Inc showing insider buying2025 Trading Volume Trends & Weekly Chart Analysis and Guides - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Travel Stocks: Does VivoSim Labs Inc have pricing powerJuly 2025 Patterns & Long-Term Capital Growth Ideas - baoquankhu1.vn
Rate Cut: Is VivoSim Labs Inc showing insider buyingQuarterly Market Review & Stock Portfolio Risk Management - baoquankhu1.vn
Sectors Review: Is SmartKem Inc part of any ETFTrade Performance Summary & Low Risk High Win Rate Picks - baoquankhu1.vn
Is VivoSim Labs Inc. benefiting from innovation trends2025 EndofYear Setup & Precise Buy Zone Identification - mfd.ru
Why VivoSim Labs Inc. stock is rated strong buyJuly 2025 Review & Risk Controlled Daily Plans - mfd.ru
VIVS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Fed Impact: Is LXFRs ROE strong enough2025 Market Sentiment & Stock Market Timing Techniques - baoquankhu1.vn
VIVS Income Statement | VIVOSIM LABS INC (NASDAQ:VIVS) - ChartMill
VivoSim (VIVS) to Present Innovative Data at SOT Meeting - GuruFocus
VivoSim to Debut Antibody Drug Conjugate Data, representing - GlobeNewswire
Shorts Report: Is VivoSim Labs Inc a stock for growth or value investors2025 Big Picture & Low Drawdown Trading Techniques - baoquankhu1.vn
Sentiment Recap: What chart patterns are forming on FTNTShort Setup & Weekly Top Performers Watchlists - baoquankhu1.vn
Aug Mood: Is VivoSim Labs Inc benefiting from innovation trendsQuarterly Market Summary & Pattern Based Trade Signal System - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Aug Fed Impact: Is Quest Resource Holding Corporation attractive at current valuationJuly 2025 Opening Moves & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Trend Recap: Does VivoSim Labs Inc have pricing powerJuly 2025 Big Picture & Safe Swing Trade Setups - baoquankhu1.vn
Morning Market Movers: FATN, FIEE, TER, PBM, See Big Swings - RTTNews
Why is VIVS stock up 79% today? - MSN
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Biotech Stocks To Keep An Eye On – January 31st - Defense World
Aug PreEarnings: Is VivoSim Labs Inc showing insider buyingM&A Rumor & Reliable Entry Point Alerts - baoquankhu1.vn
Top Biotech Stocks To Follow TodayFebruary 1st - MarketBeat
VivoSim Labs Leaps 82% Amid Strategic Partnerships in Asia - StocksToTrade
Biotech Stocks To Follow Today – January 30th - Defense World
Biotech Stocks To Keep An Eye OnJanuary 31st - MarketBeat
VivoSim Labs Shares Surge 82% Amid Key Asia Distribution Deals - StocksToTrade
VivoSim Labs Stock Soars After Major Distribution Deals in Asia - timothysykes.com
Biotech Stocks To Follow TodayJanuary 30th - MarketBeat
VivoSim Labs, Inc.Common Stock (NQ: VIVS - The Chronicle-Journal
Top Midday Gainers - marketscreener.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Gold Tumbles Over 6%; Apple Posts Upbeat Earnings - Benzinga
VivoSim Labs Expands Amid Global Market Challenges - StocksToTrade
Dow Falls Over 100 Points; Verizon Earnings Top Views - Benzinga
Morning Market Movers: TCGL, VIVS, LRHC, KXIN See Big Swings - RTTNews
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Vivosim Labs Inc (VIVS) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):